Clinical Trial Update: PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Biotheus Inc. is conducting a Phase 3 trial of PM8002 in combination with paclitaxel versus standard chemotherapy as second-line treatment for small cell lung c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• PM8002

Snippet

Sponsor: Biotheus Inc. | Conditions: SCLC | Phase 3 | Status: RECRUITING